Quarterly Result14 Nov 2026, 09:30 pm
ANG Lifesciences Declares Unaudited Financial Results for Q2 FY27
AI Summary
ANG Lifesciences India Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors also approved the appointment of Mrs. Preeti Sarin as an Additional Independent Director for a term of five years, subject to shareholder approval. Mrs. Sarin possesses over 10 years of professional experience in business administration and management.
Key Highlights
- Unaudited financial results for Q2 FY27 declared.
- Half-year financial results for the period ended 30.09.2026 approved.
- Mrs. Preeti Sarin appointed as Additional Independent Director.
- Director appointment is for a five-year term, subject to shareholder approval.
- Appointed director has over 10 years of relevant professional experience.
Price Impact
More from ANG